VAT ID: DE316949626
Synonym: LY3298176, Mounjaro®, Zepbound®, OYN3CCI6QE
Specifications
| Purity(HPLC) | ≥99.0% |
| Assay | 95.0%~105.0% (Anhydrous and Sodium-Ion-Free Basis) |
| Appearance | Lyophilized White to Off White Powder |
| Specific Rotation | -23.5° to -33.5° |
| Water Content | ≤7.0% |
| Trifluoroacetic Acid | ≤0.5% |
| Acetic Acid | ≤0.5% |
| Sodium Ion | ≤0.5% |
| Bacterial Endotoxin | <10EU/mg |
| Microbial Limits | Total Aerobic Microbial Count (TAMC) ≤100cfu/g
Total Yeasts and Mold Count (TYMC)≤100cfu/g Escherichia Coli: Not Detectable in 1g |
| Assay of Peptide | ≥95.0% |
Conforms to Standard
Safety Information
Not a hazardous substance or mixture.
DOT: Not regulated.
Additional Information
This product ships on ice via FedEx Standard Overnight® or UPS Next Day Air® with free shipping included. Freeze upon arrival. Store at -20°C.
For manufacturing, processing, R&D, analytical, and laboratory uses only. For professional use only.
Tirzepatide is a research peptide that acts as a dual GIP and GLP-1 receptor agonist. It is commonly studied for its potential effects on metabolic regulation, appetite control, insulin sensitivity, and body weight management. Researchers investigate tirzepatide for its role in supporting glucose metabolism, reducing food intake, and promoting weight reduction through its interaction with incretin hormone pathways.
In research settings, tirzepatide has been explored for applications related to obesity, metabolic function, and glucose regulation. Its mechanism involves influencing signals that help regulate blood sugar levels, digestion speed, and feelings of fullness.
Reviews
There are no reviews yet.